Sally Bennett

Sally Bennett

Director/Board Member presso BERGENBIO ASA

Patrimonio netto: 5 900 $ in data 31/03/2024

52 anni
Finance
Health Technology
Commercial Services

Profilo

Sally Bennett is currently an Independent Non-Executive Director at BerGenBio ASA since 2020.
She is also a Director at P4 Precision Medicine Accelerator and an Independent Member-Supervisory Board at Innate Pharma SA since 2022.
Additionally, she is a Member at The Institute of Directors and a Member-Governors Council at University College London Hospitals NHS Foundation Trust.
In her former positions, Dr. Bennett worked as an Analyst at ING Bank NV (United Kingdom) and as a Senior Member at HealthCor Management LP.
She also served as a Senior Research Analyst at Piper Sandler Ltd.
from 2006 to 2007 and as an Analyst at Healthcor Management UK LLP from 2008 to 2014.
Dr. Bennett completed her undergraduate and doctorate degrees at The University of Manchester.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/12/2022 2 500 ( 0.00% ) 5 900 $ 31/03/2024

Posizioni attive di Sally Bennett

SocietàPosizioneInizio
BERGENBIO ASA Director/Board Member 09/12/2020
INNATE PHARMA Director/Board Member 20/05/2022
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
Tutte le posizioni attive di Sally Bennett

Precedenti posizioni note di Sally Bennett

SocietàPosizioneFine
Healthcor Management UK LLP Analyst-Equity 02/07/2014
Analyst-Equity 30/04/2007
Corporate Officer/Principal -
ING Bank NV (United Kingdom) Analyst-Equity -
Vedi nel dettaglio l'esperienza di Sally Bennett

Formazione di Sally Bennett

The University of Manchester Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Sally Bennett

Relazioni

100 +

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
INNATE PHARMA

Health Technology

BERGENBIO ASA

Health Technology

Aziende private7
ING Bank NV (United Kingdom)

Finance

Finance

Finance

Commercial Services

Healthcor Management UK LLP

Finance

Health Services

Commercial Services

Vedi le connessioni aziendali